Jo and colleagues used a dual AAV vector encoding CRISPR/Cas9, and an RPE65 donor sequence to target exon 3 of RPE65 leading to the removal of the premature stop codon that caused LCA and restored retinal function in rd12 mouse model 121 (Figure 14A-D). Here, RPE65 is linked to Leber congenital amaurosis.